0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis
NCT02241174 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2015-10-20
Summary
This study will determine the safety and efficacy of diluted bleach bath solution as final rinse on the reduction of Staphylococcus aureus colonization among children and adult Filipinos with mild to moderate atopic dermatitis..
Conditions
Interventions
- DRUG
-
Sodium Hypochlorite
The 0.005% sodium hypochlorite solutions will be prepared from the commercially available Clorox® at 6% solution. 0.83ml of the 6% sodium hypochlorite solution will be taken and incorporated to a-100ml absolute distilled water. This 100ml solution will be stored in an amber glass bottle at room temperature unexposed to light at a maximum of 23 months
Sponsors & Collaborators
-
Makati Medical Center
lead OTHER
Principal Investigators
-
Donna Marie L. Sarrosa, MD, FPDS · Makati Medical Center
-
Jamaine Melisse L Cruz, MD · Makati Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2014-12-31
- Completion
- 2015-02-28
Countries
- Philippines
Study Locations
More Related Trials
-
Evaluating the Effect of Bathing Additives in Atopic Dermatitis
NCT04001855 ·Status: TERMINATED ·Phase: NA
-
Bathing Additives in Pediatric Atopic Dermatitis
NCT02582788 ·Status: TERMINATED ·Phase: NA
-
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
NCT06397781 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis
NCT04635072 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children
NCT05443490 ·Status: TERMINATED ·Phase: NA
-
Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
NCT00560326 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
NCT02748993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
NCT02118766 ·Status: COMPLETED ·Phase: PHASE3
-
S. Aureus Colonization in Atopic Dermatitis
NCT02091037 ·Status: COMPLETED
-
Topical Application of AS101 for the Treatment of Atopic Dermatitis
NCT00927212 ·Status: TERMINATED ·Phase: PHASE2
-
Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic Dermatitis
NCT05092464 ·Status: UNKNOWN ·Phase: NA
-
Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy
NCT00871208 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
NCT02757729 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
NCT02118792 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
NCT00691262 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children
NCT01772056 ·Status: TERMINATED ·Phase: PHASE3
-
A Trial of Antroquinonol in Patients With Atopic Dermatitis
NCT03622463 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
NCT01602341 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis
NCT03091426 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis
NCT00150059 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
NCT00691145 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction
NCT07183423 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.
NCT03052348 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba
NCT03834935 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
NCT01782729 ·Status: COMPLETED ·Phase: PHASE4